NLRP3 and metabolic dysfunction-associated steatotic liver disease: Given that NLRP3 is a downstream target of NF-κB and the NF-κB/NLRP3 signaling pathway plays a pivotal role in NAFLD-related inflammation, we hypothesize that HH may exert potent anti-inflammatory effects by regulating this signaling pathway.